Investigators sought to determine whether adjuvant pembrolizumab is associated with the risk of developing subsequent cutaneous malignant neoplasms in patients with high-risk stage II melanoma ...

New research from McMaster University suggests that wearable trackers can detect the subtle signs of a depression relapse ...

Actigraphy data show irregular sleep-wake rhythms nearly double the risk for relapse in individuals with remitted major depressive disorder.

Continued treatment with Briumvi provided sustained clinical benefits to patients with relapsing MS, particularly when ...

An existing drug currently used to treat glaucoma, altitude sickness, and seizures may also have the potential to prevent ...

Wearable trackers could even detect the probability of a relapse weeks or months before it occurs. Up to around 60% of people with MDD will experience at least one relapse episode in their lifetime.

For decades, prevailing wisdom held that to overcome addiction, the most important thing to do was to flush or “clean” the drugs out of one’s system, to get a fresh start. But more and more, research ...

Addiction has causes that are neurobiological, psychological and structural. Treating these drivers is as important as ...

Objectives Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) is a systemic autoimmune disease where infections ...